Understanding and Managing Neurodevelopmental Disorders in Children and Adolescents

Children are being identified with more neurodevelopmental disorders than in previous decades and understanding these medically complex disorders has become critical as more children are living with these disorders.

Autorentext

Denise E. Maricle, Ph.D., LP-MN, NCSP, ABSNP retired from academia in 2023. Over the past 30+ years, Dr. Maricle has practiced as a psychologist, school psychologist, pediatric/school neuropsychologist, and an academician and researcher. She currently engages in writing, training, and consultancy work.

Christopher L. Bedford, Ph.D., LP, ABSNP is the executive director of the American Board of School Neuropsychology. Working as a psychologist for more than 15 years, Dr. Bedford currently operates a private practice in Minnesota.

Julie A. Gettman, Ph.D., NCSP, ABSNP is the executive director of the School Neuropsychology Institute. She owns and operates Mindworks Assessment, a private practice and consulting company specializing in comprehensive neurocognitive assessment for children and adolescents.

Daniel C. Miller, Ph.D., ABPP, ABSNP is the founder of the School Neuropsychology Institute, president of KIDS, Inc., and founder of Report Insights LLC. He has more than 35+ years of experience in school psychology and school neuropsychology. He is the executive director of the Woodcock Institute for Neurocognitive Research and Applied Practice.

Wendi L. Johnson, Ph.D., LP, NCSP, LSSP is an associate professor at Texas Woman's University, and the assistant executive director of the Woodcock Institute for Neurocognitive Research and Applied Practice. Dr. Johnson currently serves as director of the Woodcock Autism Assessment Clinic (WAAC).

Inhalt

Section 1: Neurodevelopmental Disorders An Introduction 1. Advancing Practice in Neurodevelopment 2. School Integration for Children with Medical/Physical Disorders and Complex Medical Needs 3. Prematurity and Related Complications Section 2: Metabolix, Toxic, and Inflammatory Disorders 4. Inflammation of the Brain: Pediatric Encephalitis and Meningitis 5. Neonatal Abstinence Syndrome (NAS) 6. Fetal Alcohol Spectrum Disorders (FASDs) 7. Neurotoxins and Pediatric Poisoning 8. Viral Infections 9. Covid-19 and Long Covid in Children 10. Autoimmune Disorders: Pediatric Myalgic Encephalomyelitis/Chronic Fatigue (ME/CFS), Pediatric Gullain Barre Syndrome (GBS) and Juvenile Fribomyalgia Syndrome (JPFS) 11. Juvenile Arthritis 12. Postural Orthostatic Tachycardia Syndrome (POTS) and Ehlers Danlos Syndrome (EDS) in Pediatric Patients Section 3: Medically Complex Disorders 13. Epilepsy and Seizures in Children and Adolescents 14. Evaulation and Management of Neurocognitive Dysfunction in Children and Adolescents with Type 1 Diabetes 15. Pediatric Stroke/Cardiovascular Accident (CVA) Section 4: Genetic and Chromosomal Disorders 16. Sickle Cell Disease (SCD) 17. Cystic Fibrosis 18. Genetic Disorders Impacting Cognition 19. Deletion Disorders 20. Neurofibromatosis Type 1 and Neurofibromatosis Type 2-Related Schwannomatosis Section 5: Malformations of Brain and Spine 21. Spina Bifida 22. Chiari Malformation 23. Cerebral Palsy 24. Demyelinating Disorders Index